Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Association of Cardiovascular Disease With Respiratory Disease
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Dapagliflozin for treating chronic heart failure with reduced ejection fraction